Souhaitez-vous accéder aux communiqués récents ?

Austin, United States, April 21, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, The Phage Therapy Market Size is valued at USD 1.27 Billion in 2025 and is projected to reach USD 1.86 Billion by...

EDMONTON, Alberta , April 19, 2026 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc., a leader in the development of drugs to treat antibiotic-resistant infections, is presenting a full suite of...

Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "Antimicrobial Resistance (AMR) and 'One Health': Current Challenges, Regulatory Frontiers and Future Solutions (June 10, 2026)" training has been...

Austin, United States, April 02, 2026 (GLOBE NEWSWIRE) -- As per SNS Insider, The Antimicrobial Resistance Surveillance Market size was valued at USD 6.56 Billion in 2025 and is projected to reach...

Dublin, Feb. 25, 2026 (GLOBE NEWSWIRE) -- The "Antimicrobial Resistance (AMR) and 'One Health': Current Challenges, Regulatory Frontiers and Future Solutions Training Course (June 10, 2026)"...

Dublin, Feb. 03, 2026 (GLOBE NEWSWIRE) -- The "Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, With Executive Guides and Customization" report has been...

Dublin, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The "Carbapenem-resistant Enterobacteriaceae Infection Market - A Global and Regional Analysis: Focus Country and Regional Analysis, 2025-2035" has been...

EDMONTON, Alberta , Jan. 29, 2026 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc., a leader in the development of drugs to treat antibiotic-resistant infections, is presenting four posters at the...

Edmonton, Alberta, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc., a leader in the development of drugs to treat antibiotic-resistant infections, announced plans to unveil the...

“Antimicrobial resistance is advancing silently, but its consequences are all too real"